Biological treatments in allergy: prescribing patterns and management of hypersensitivity reactions

Leyla Barakat; Maria Jose Torres; Elizabeth Phillips; Marco Caminati; Yoon-Seok Chang; Davide Caimmi; Mario Sanchez-Borges; Lanny Rosenwasser; Alain Didier; Frédéric de Blay; Jean-François Fontaine; Isabelle Bosse; Sebastien Lefevre; Cintia Bassani; Maria de Filippo; Igancio Asontegui; Mario Morais-Almeida; Motohiro Ebisawa; Bryan Martin; Bernard Yu-Hor Thong; Pascal Demoly; Luciana Kase Tanno

doi:10.1016/j.jaip.2020.10.044

Back

Biological treatments in allergy: prescribing patterns and management of hypersensitivity reactions

Journal article

Open access

Peer reviewed

Biological treatments in allergy: prescribing patterns and management of hypersensitivity reactions

Leyla Barakat, Maria Jose Torres, Elizabeth Phillips, Marco Caminati, Yoon-Seok Chang, Davide Caimmi, Mario Sanchez-Borges, Lanny Rosenwasser, Alain Didier, Frédéric de Blay, …

Journal of Allergy and Clinical Immunology: In Practice, Vol.9(3), pp.1396-1399.e2

03/2021

DOI: https://doi.org/10.1016/j.jaip.2020.10.044

PMID: 33161172

Abstract

Drug Hypersensitivity / diagnosis

Drug Hypersensitivity / therapy

Humans

Hypersensitivity / therapy

Skin Tests

Biological agents (BA) are emerging as potential effectivetreatment for allergic and hypersensitivity disorders (A/H). Fourmain classes of BA are now (May 2020) approved by US Foodand Drug Administration and European Medicines Agency forA/H: anti-IgE (omalizumab),1 anti-IL5 (mepolizumab, reslizu-mab),2 anti-IL4/13 (dupilumab),3 and anti-IL5R (benralizu-mab).4 Hypersensitivity reactions (HSR) due to BA can occurwith different severity degrees, which hamper their use. Newtypes of HSR have been reported with lack of standardized andguided allergy workup

Files and links (2)

url

Find in HALView

url

https://doi.org/10.1016/j.jaip.2020.10.044View

Published (Version of record) Open

Metrics

1 Record Views

See more details

Details

Title: Biological treatments in allergy: prescribing patterns and management of hypersensitivity reactions
Creators - without role: Leyla Barakat - Département pneumologie et addictologie [Montpellier]
Maria Jose Torres - Hospital Regional Universitario de Málaga
Elizabeth Phillips - Vanderbilt University Medical Center
Marco Caminati - University of Verona
Yoon-Seok Chang - Seoul National University Bundang Hospital
Davide Caimmi - Département pneumologie et addictologie [Montpellier]
Mario Sanchez-Borges - Hospital Clínico Universitario de Caracas
Lanny Rosenwasser - Children's Mercy Hospital
Alain Didier - Centre de Physiopathologie Toulouse Purpan
Frédéric de Blay - Hôpitaux Universitaires de Strasbourg
Jean-François Fontaine - Vaincre la Mucoviscidose
Isabelle Bosse - Syndicat français des allergologues
Sebastien Lefevre - Centre Hospitalier Régional de Metz-Thionville
Cintia Bassani - Faculdade Meridional
Maria de Filippo - Policlinico San Matteo Fondazione
Igancio Asontegui - Hospital Quirónsalud Barcelona
Mario Morais-Almeida - Hospital do Desterro
Motohiro Ebisawa - National Sagamihara Hospital
Bryan Martin - The Ohio State University
Bernard Yu-Hor Thong - Tan Tock Seng Hospital
Pascal Demoly - Institut Universitaire de Recherche Clinique
Luciana Kase Tanno - Département pneumologie et addictologie [Montpellier]
Publication Details: Journal of Allergy and Clinical Immunology: In Practice, Vol.9(3), pp.1396-1399.e2
Identifiers: 9937369309311
Academic Unit: Institut Desbrest d Epidemiologie et de Sante Publique - IDESP
Language: English
Resource Type: Journal article
Local Fields: hal-03231340